| Breakdown | TTM | Nov 2025 | Nov 2024 | Nov 2023 | Nov 2022 | Nov 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 33.14B | 34.19B | 35.48B | 34.29B | 33.71B | 27.14B |
| Gross Profit | 5.56B | 6.07B | 8.01B | 8.23B | 9.20B | 7.34B |
| EBITDA | 2.45B | 2.96B | 5.32B | 5.33B | 6.12B | 5.93B |
| Net Income | 1.79B | 2.06B | 3.93B | 3.94B | 4.61B | 4.43B |
Balance Sheet | ||||||
| Total Assets | 33.21B | 34.43B | 41.31B | 39.23B | 37.98B | 33.21B |
| Cash, Cash Equivalents and Short-Term Investments | 2.09B | 3.80B | 4.98B | 6.56B | 4.79B | 2.93B |
| Total Debt | 4.32B | 6.32B | 4.45B | 5.14B | 6.36B | 6.54B |
| Total Liabilities | 11.18B | 12.29B | 13.29B | 12.53B | 13.74B | 12.21B |
| Stockholders Equity | 21.88B | 21.96B | 27.87B | 26.58B | 24.10B | 20.82B |
Cash Flow | ||||||
| Free Cash Flow | 14.77M | 28.18M | 2.23B | 5.08B | 3.21B | 2.47B |
| Operating Cash Flow | 177.35M | 216.81M | 2.40B | 5.18B | 3.27B | 2.53B |
| Investing Cash Flow | 178.81M | 221.57M | -302.56M | -176.98M | -128.30M | -105.09M |
| Financing Cash Flow | -549.37M | -1.60B | -3.68B | -3.25B | -1.28B | -2.40B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | $18.07B | 23.10 | 34.29% | ― | -6.68% | -16.31% | |
74 Outperform | $24.30B | 16.24 | 15.92% | 0.78% | -5.94% | -27.06% | |
72 Outperform | $45.34B | 15.24 | 13.24% | 1.14% | -5.57% | -19.40% | |
69 Neutral | $13.89B | 16.39 | 16.86% | 0.70% | 4.60% | -3.85% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
61 Neutral | $3.46B | 29.80 | 9.01% | 1.76% | -13.61% | -37.18% | |
56 Neutral | $23.09B | 30.47 | 8.04% | 1.91% | -7.52% | -49.33% |